Evaluation of the Fluoride Dose Response Using In Situ Caries Model
NCT04763044
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Caries
Interventions
DRUG:
0 ppm F
DRUG:
250 ppm F as MFP
DRUG:
1100 ppm as MFP
DRUG:
2800 ppm F as MFP
DRUG:
1100 ppm SnF2
Sponsor
Procter and Gamble